Successful mechanical thrombectomy of the left superior cerebellar artery
Authors:
K. Zeleňák 1; L. Meyer 2; E. Kurča 3; S. M. M. Bhaskar 4; J. Fiehler 2
Authors place of work:
Clinic of Radiology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
1; Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2; Clinic of Neurology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia
3; University of New South Wales (UNSW), South-Western Sydney Clinical School, NSW, Australia
4
Published in the journal:
Cesk Slov Neurol N 2022; 85(2): 176-178
Category:
Dopisy redakci
doi:
https://doi.org/10.48095/cccsnn2022176
Dear editor,
Endovascular treatment is recommended as standard therapy of acute ischemic stroke with large vessel occlusion (LVO). The effectiveness of mechanical thrombectomy (MT), performed in comprehensive stroke centers, was confirmed for posterior circulation with primary and secondary distal medium vessel occlusions (DMVO) [1,2] with a similar safety profile compared to the proximal LVO group [3]. When symptoms are pronounced, the benefit of the procedure outweighs the risks [4]. Swollen cerebral and cerebellar infarcts are critical conditions that warrant immediate, specialized neurointensive care and often neurosurgical intervention. A decompressive craniectomy is a necessary option in many patients [5]. The safety and effectiveness of MT for cerebellar arteries have not been established yet. Only limited information can be found in the literature [6–8]. Overall, posterior inferior cerebellar artery (PICA) strokes are more common than superior cerebellar artery (SCA) strokes, and anterior inferior cerebellar artery (AICA) strokes are the least common [9].
A 22-year-old woman, smoker, and contraceptive user suffered a stroke in October 2020. According to information from her parents, she had a sudden loss of consciousness. Her initial National Institutes of Health Stroke Scale (NIHSS) in the primary hospital was 25 and her Glasgow Coma Scale (GCS) was 10. Her dominant neurological signs were: quadriparesis (dominant on the right side), mydriasis on the left side, nausea, and vomiting. CTA confirmed a distal basilar artery occlusion. The patient received a full dose of intravenous thrombolysis, and she was then transferred to an endovascular center. After transport to the endovascular center, her clinical status improved only partially. Her actual admission NIHSS was 10. Dysarthria, nausea and vomiting, and right hemiataxia were still present. Intracranial hemorrhage was excluded by CT and the patient was transferred to the catheterization room.
The procedure was performed under general anesthesia to prevent aspiration. The right common femoral artery was punctured under ultrasound guidance and a 6F short sheath was placed by the Seldinger technique. The patient was not heparinized. Over the guidewire, the sheath was replaced by a 6F 80 cm long introducer, which was placed into the left subclavian artery and a 6F guiding catheter was positioned coaxially into the left vertebral artery. All catheters were flushed with saline solution continuously.
The left vertebral artery angiogram positively confirmed basilar artery recanalization, but the left SCA occlusion was still present (Fig. 1A). The microcatheter Excelsior SL-10/ 90 (Stryker Neurovascular, Fremont, CA, USA) was navigated into the left SCA by Hybrid 008.J guidewire (Balt, Montmorency, France), and Actilyse (Boehringer Ingelheim Pharma GmbH, Ingelheim am Rhein, Germany) at a dose of 2 x 1 mg was injected into the left sac. The next angiogram proved no SCA recanalization. The same microcatheter was placed again into the left SCA and the thrombectomy device pRESET LITE 3 x 20 mm (Phenox, Bochum, Germany) was delivered into the left SCA occlusion (Fig. 1B). MT was performed in conjunction with aspiration via 6F aspiration catheter Sofia Plus 6F (MicroVention, Tustin, CA, USA) placed in the basilar artery. The first-pass effect and complete SCA recanalization were achieved (Fig. 1C, D). Time from onset to SCA recanalization was 4 h and 40 min. Cumulative fluoroscopy time was 10 min and 9 s. No hemorrhagic transformation occurred on follow-up imaging. The patient recovered completely. Her modified Rankin Scale score at discharge and at 3 months was 0. Patent foramen ovale and thrombosis of the right external iliac vein were diagnosed during her hospital stay. The foramen ovale was treated by occluder implantation and the right external iliac vein thrombosis was addressed by standard medical treatment (low molecular weight heparin). No recurrence of symptoms occurred in the next follow-up period. Follow- up CTA confirmed patency of the SCA.
Occlusions of cerebellar arteries are quite uncommon. Overall, PICA strokes are more common than SCA strokes and AICA strokes are the least common [9]. Thanks to technical improvement, DMVO recanalization is carried out more often. The safety and effectiveness of MT for cerebellar arteries have not been established yet. Only limited information can be found in the literature [6–8]. Yin et al described MT for a mural thrombus covering the opening of the SCA [6].
In our case, the probable source of the embolism was thrombosis of the right external iliac vein, thanks to the patent foramen ovale. Basilar artery occlusion was dissolved by standard intravenous thrombolysis, but DSA confirmed residual left SCA occlusion. SCA supplies important neurological structures: posterolateral midbrain (and upper lateral pons): cranial nerves nuclei (IV, V) and fascicle (IV); sympathetic tract; spinothalamic tract; medial lemniscus; superior cerebellar peduncle; superior cerebellum, including superior vermis; and dentate nucleus [9]. Therefore, endovascular treatment was contemplated. The patient‘s parents were informed about the options of endovascular treatment. Their informed consent was achieved over the telephone.
The procedure was performed under general anesthesia to prevent SCA perforation and patient aspiration. Initially, super-selective intra-arterial thrombolysis was used because of the potential risk of SCA injury during more aggressive manipulation. MT was used after intra-arterial thrombolysis failure. A lowprofile microcatheter and thrombectomy device were used achieving complete SCA recanalization. The patient recovered promptly after endovascular treatment with no residual neurological deficits. No hypercoagulation hematology disease was diagnosed. The foramen ovale was treated by occluder implantation to prevent another paradoxical thromboembolism originating from deep vein thrombosis. No recurrence of symptoms occurred in the next follow-up period. Followup CTA confirmed the patent SCA.
Acute embolism of the SCA after intravenous thrombolysis of the basilar artery is rarely reported. Endovascular treatment of SCA occlusion is technically feasible thanks to advanced endovascular devices. The patient recovered completely.
Funding
This publication has been produced with the support of the Integrated Infrastructure Operational Program for the project: Creation of a Digital Biobank to support the systemic public research infrastructure, ITMS: 313011AFG4, co-financed by the European Regional Development Fund.
Redakční rada potvrzuje, že rukopis práce splnil ICMJE kritéria pro publikace zasílané do biomedicínských časopisů.
The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.
Accepted for review: 19. 2. 2022
Accepted for print: 13. 4. 2022
Assoc. Prof. Kamil Zeleňák, MD, PhD
Clinic of Radiology
Jessenius Faculty of Medicine
in Martin
Comenius University
Kollárova 2
03659 Martin
Slovakia
e-mail: kamil.zelenak@uniba.sk
Zdroje
1. Meyer L, Stracke CP, Jungi N et al. Thrombectomy for primary distal posterior cerebral artery occlusion stroke: The TOPMOST Study. JAMA 2021; 78(4): 434–444. doi: 10.1001/ jamaneurol.2021.0001.
2. Meyer L, Stracke CP, Wallocha M et al. Thrombectomy for secondary distal, medium vessel occlusions of the posterior circulation: seeking complete reperfusion. J Neurointerv Surg 2021 [ahead of print]. doi: 10.1136/ neurintsurg-2021-017742.
3. Broocks G, Elsayed S, Kniep H et al. Early prediction of malignant cerebellar edema in posterior circulation stroke using quantitative lesion water uptake. Neurosurgery 2021; 88(3): 531–537. doi: 10.1093/ neuros/ nyaa438.
4. Anadani M, Alawieh A, Chalhoub R et al. Mechanical thrombectomy for distal occlusions: efficacy, functional and safety outcomes: insight from the STAR collaboration. World Neurosurg 2021; 151: e871–e879. doi: 10.1016/ j.wneu.2021.04.136.
5. Wijdicks EF, Sheth KN, Carter BS et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2014; 45(4): 1222–1238. doi: 10.1161/ 01.str.0000441965.15164.d6.
6. Yin C, Ding Y, Sun B et al. Mechanical embolectomy for superior cerebellar artery embolism. J Craniofac Surg 2021 [ahead of print]. doi: 10.1097/ SCS.0000000000 008055.
7. Choi BS, Lee H, Jin SC. Contralateral Mechanical thrombectomy of partial deployed stent retrieval for acute anterior inferior cerebellar artery occlusion. World Neurosurg 2019; 129: 318–321. doi: 10.1016/ j. wneu.2019.06.044.
8. Zhang HB, Wang P, Wang Y et al. Mechanical thrombectomy for acute occlusion of the posterior inferior cerebellar artery: A case report. W J Clin Cases 2021; 9(10): 2268–2273. doi: 10.12998/ wjcc.v9.i10. 2268.
9. Edlow JA, Newman-Toker DE, Savitz SI. Diagnosis and initial management of cerebellar infarction. The Lancet. Neurology 2008; 7(10): 951–964. doi: 10.1016/ S1474- 4422(08)70216-3.
10. Styczen H, Fischer S, Yeo LL et al. Approaching the boundaries of endovascular treatment in acute ischemic stroke: multicenter experience with mechanical thrombectomy in vertebrobasilar artery branch occlusions. Clin Neuroradiol 2021; 31(3): 791–798. doi: 10.1007/ s00062-020-00970-7.
Štítky
Dětská neurologie Neurochirurgie NeurologieČlánek vyšel v časopise
Česká a slovenská neurologie a neurochirurgie
2022 Číslo 2
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejčastější nežádoucí účinky venlafaxinu během terapie odeznívají
- Pregabalin je účinné léčivo s příznivým bezpečnostním profilem pro pacienty s neuropatickou bolestí
- Neodolpasse je bezpečný přípravek v krátkodobé léčbě bolesti
Nejčtenější v tomto čísle
- Targeted surgery for obstructive sleep apnea
- Balance disorders in patients with multiple sclerosis and possible rehabilitation therapy – current findings from controlled clinical trials
- Successful nonsurgical management of lumbar radiculopathy associated with disc herniation and instability in low back pain syndrome
- Historical scope of the swallowing postures and maneuvers in the behavioral treatment of oropharyngeal dysphagia